Literature DB >> 8851506

Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8).

M Yoshida1, M Kikukawa, H Hisa, S Satoh.   

Abstract

1. The aim of this study was to investigate the renal vascular response to angiotensin II (3-8) (AIV). The effect of the nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME) or the cyclooxygenase inhibitor, indomethacin on the AIV-induced response was examined in anaesthetized spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). 2. Intrarenal infusion of AIV produced a biphasic vasoconstrictor response. The vasoconstriction developed rapidly to reach a maximum followed by a partial recovery to a sustained lesser level of vasoconstriction. The initial maximum response was enhanced by L-NAME but not affected by indomethacin treatment. The simultaneous administration of L-NAME and indomethacin prevented the partial recovery resulting in a greater sustained level of constriction. 3. A stable vasoconstriction of relatively constant magnitude was observed with angiotensin II (AII) infusion. The AII vasoconstriction was enhanced by L-NAME but not changed by indomethacin. The combination of these inhibitors further enhanced the AII-induced vasoconstriction in WKY, but not in SHR. 4. Pretreatment with the AII receptor antagonist, losartan, inhibited the vasoconstriction induced by AIV and AII. 5. These results suggest that nitric oxide and prostaglandins may modulate the renal vascular response to AIV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851506      PMCID: PMC1909409          DOI: 10.1111/j.1476-5381.1996.tb15276.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture.

Authors:  M G Doni; B J Whittle; R M Palmer; S Moncada
Journal:  Eur J Pharmacol       Date:  1988-06-22       Impact factor: 4.432

2.  Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.

Authors:  J W Aiken; J R Vane
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

Review 3.  Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension.

Authors:  L M Ruilope; V Lahera; J L Rodicio; J C Romero
Journal:  J Hypertens       Date:  1994-06       Impact factor: 4.844

4.  Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.

Authors:  S Ito; C S Johnson; O A Carretero
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Structure-function analyses of brain angiotensin control of pressor action in rats.

Authors:  J W Wright; L L Jensen; K A Roberts; M F Sardinia; J W Harding
Journal:  Am J Physiol       Date:  1989-12

6.  Nitric oxide-mediated changes in vascular reactivity in pregnancy in spontaneously hypertensive rats.

Authors:  Z M Chu; L J Beilin
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.

Authors:  Y Uehara; N Hirawa; Y Kawabata; T Suzuki; N Ohshima; K Oka; T Ikeda; A Goto; T Toyo-oka; K Kizuki
Journal:  Hypertension       Date:  1994-12       Impact factor: 10.190

8.  The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon.

Authors:  J T Fitzsimons
Journal:  J Physiol       Date:  1971-04       Impact factor: 5.182

9.  Vascular effects and metabolism of angiotensins and their metabolites in the isolated perfused rat kidney.

Authors:  J Misumi; M F Gonzales; T Ogihara; P Corvol; J Ménard
Journal:  Clin Exp Hypertens A       Date:  1983

10.  Role of prostaglandins and endothelium-derived relaxing factor on the renal response to acetylcholine.

Authors:  M G Salom; V Lahera; J C Romero
Journal:  Am J Physiol       Date:  1991-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.